bullish
Chugai Pharma (4519) - ALEX Trials for Alecensa a Success
155 Views12 Apr 2017 17:07
Chugai Pharmaceutical (4519 JP) completed the clean sweep on Phase III trials for Alecensa. The latest data, from the ALEX trial, showed its...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
Pelham Smithers Associates
Market Intel on Asian Tech with a Japan focus
Price Chart(Sign Up to Access)
- Chugai Pharma (4519) - ALEX Trials for Alecensa a Success12 Apr 2017
- Chugai Pharmaceutical: Update Ahead of Summer Data Releases07 Apr 2017
x